Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Return on Assets [ROA] (2023 - 2026)

Updated

Indivior Pharmaceuticals (INDV) recorded Return on Assets [ROA] of 35.09% in Q3 2026, up 26.09 percentage points from 9.00% a year earlier and up 5.87 percentage points from the prior quarter.

Analysis

Supernus (INDV) Return on Assets [ROA] (2023 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals reported Return on Assets [ROA] of 16.69%, up 16.23 percentage points from FY2024.

  • Across earlier years, Return on Assets [ROA] came in at 0.46% in FY2024.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at 29.22% (Q2 2026), 20.93% (Q1 2026) and 16.05% (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 35.09%
Jun 30, 2026 29.22%
Mar 31, 2026 21.10%
Dec 31, 2025 16.20%
Sep 30, 2025 8.30%
Jun 30, 2025 5.73%
Mar 31, 2025 -2.68%
Dec 31, 2024 -1.58%
Sep 30, 2024 1.53%
Jun 30, 2024 -7.76%
Mar 31, 2024 4.11%
Dec 31, 2023 4.21%
Sep 30, 2023 -8.99%
API Access

Supernus Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INDV&period=max&api_key=YOUR_API_KEY